In general, interactions between lipid metabolism and AD pathogenic mechanisms have been described; specifically, ceramides, cholesterol, and gangliosides showed a relationship with amyloid pathology, and also cholesterol showed a relationship with tau [18]. This evidence concerns the gene MAPT and Alzheimer disease.